Galeterone(VN/124-1,TOK001) is a highly selective, multi-targeted, oral small molecule, drug candidate for the treatment of prostate cancer that disrupts androgen receptor (AR) signaling, the key driver of prostate cancer growth, via multiple mechanisms of action.
For research use only. We do not sell to patients.
Name | Galeterone |
---|---|
Iupac Chemical Name | 17-(1H-benzimidazol-1-yl)androsta-5,16-dien-3��-ol |
Synonyms | VN/124-1,TOK001 |
Molecular Formula | C26H32N2O |
Molecular Weight | 388.25 |
Smile | C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4n5cnc6c5cccc6)C)O |
InChiKey | PAFKTGFSEFKSQG-PAASFTFBSA-N |
InChi | InChI=1S/C26H32N2O/c1-25-13-11-18(29)15-17(25)7-8-19-20-9-10-24(26(20,2)14-12-21(19)25)28-16-27-22-5-3-4-6-23(22)28/h3-7,10,16,18-21,29H,8-9,11-15H2,1-2H3/t18-,19-,20-,21-,25-,26-/m0/s1 |
CAS Number | 851983-85-2 |
MDL | MFCD16660907 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | off-white solid |
---|---|
Purity | 98% by HPLC(254nm or 214nm) |
Storage | 3 years -20ºCpowder |
Solubility | Soluble in DMSO,CDCl3 |
Handling | |
Shipping Condition | Shipped under ambient temperature. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |